. . . . . . . . . "\"Trandolapril tablets are contraindicated in patients who are hypersensitive to this product, in patients with hereditary/idiopathic angioedema and in patients with a history of angioedema related to previous treatment with an ACE inhibitor. Do not co-administer aliskiren with trandolapril in patients with diabetes (see PRECAUTIONS, Drug Interactions Trandolapril tablets are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer trandolapril tablets within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor (see WARNINGS\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "KqbwjYH2U/Rh2leW3QeQZWMiuN1bWjM+pbnr7JCU0Xwu+HHpf1UnVfGMyh/clYtMPx+AMMTUDOVwnGmGmvv676OO0LgjDvLj03Wq6rl4zpVdWeoFCp7MWMI2HMnF0f8AGXSPGKv6pHt/P2imxErJ0nLuLx+RYp8fYQcpI4Phhl8=" . . "2021-08-25T13:54:45.572+02:00"^^ . . . . .